Estrogen-Suppressing Drugs Substantially Reduce Breast Cancer Deaths
A class of hormonal drugs called aromatase inhibitors substantially reduce the risk of death in postmenopausal women with the most common type of breast cancer, a major study of more than 30,000 women shows.
The research underlines the importance of aromatase inhibitors in the treatment of oestrogen receptor (ER)-positive breast cancer - and shows they reduce risk of death by significantly more than the older hormonal treatment tamoxifen.
The study published in The Lancet is relevant to postmenopausal women with ER-positive breast cancer, which accounts for over 80 per cent of cases which…